🇺🇸 FDA
Pipeline program

Lenalidomide combined with G-CHOP (LO CHOP)

XMDYYYXYK-01

Phase 2 small_molecule active

Quick answer

Lenalidomide combined with G-CHOP (LO CHOP) for DLBCL - Diffuse Large B Cell Lymphoma is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
DLBCL - Diffuse Large B Cell Lymphoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials